Sleep duration and cancer risk: A systematic review and meta-analysis of prospective studies

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7509-7515

  Zhao, Hao ^a,b,c   Yin, Jie Yun ^b   Yang, Wan Shui ^a   Qin, Qin ^b   Li, Ting Ting ^b   Shi, Yun ^b   Deng, Qin ^a   Wei, Sheng ^b   Liu, Li ^b   Wang, Xin ^a   Nie, Shao Fa ^b  

^a JIUJIANG UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

Cancer risk; Hormone related cancers; Meta analysis; Sleep duration

Indexed keywords

ARTICLE; HUMAN; META ANALYSIS; NEOPLASM; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SLEEP; SLEEP DISORDER; TIME;

HUMANS; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SLEEP; SLEEP DISORDERS; TIME FACTORS;

EID: 84893397050     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7509     Document Type: Article

References (48)

1. Aeschbach D, Sher L, Postolache TT, et al (2003). A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab, 88, 26-30.
2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
3. Benke KK, Benke KE (2013). Uncertainty in Health Risks from Artificial Lighting due to Disruption of Circadian Rhythm and Melatonin Secretion: A Review. Human Ecol Risk Assess, 19, 916-29.
4. Cappuccio FP, D'Elia L, Strazzullo P, et al (2010a). Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care, 33, 414-20.
5. Cappuccio FP, D'Elia L, Strazzullo P, et al (2010b). Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Slee, 33, 585-92.
6. Cappuccio FP, Taggart FM, Kandala NB, et al (2008). Metaanalysis of short sleep duration and obesity in children and adults. Sleep, 31, 619-26.
7. Cohen M, Lippman M, Chabner B (1978). Role of pineal gland in aetiology and treatment of breast cancer. Lancet, 2, 814-6.
8. Cutando A, Aneiros-Fernandez J, Aneiros-Cachaza J, et al. (2011). Melatonin and cancer: current knowledge and its application to oral cavity tumours. J Oral Pathol Me, 40, 593-7.
9. Di Bella G, Mascia F, Gualano L, et al (2013). Melatonin anticancer effects: review. Int J Mol Sci, 14, 2410-30.
10. Egger M, Davey Smith G, Schneider M, et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
11. Ferrie JE, Shipley MJ, Cappuccio FP, et al (2007). A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep, 30, 1659-66.
12. Gallicchio L, Kalesan B (2009). Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res, 18, 148-58.
13. Girschik J, Heyworth J, Fritschi L (2010). Re: "Night-shift work and breast cancer risk in a cohort of Chinese women". Am J Epidemiol, 172, 865-6; author reply 67-8.
14. Greenland S, Longnecker MP (1992). Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol, 135, 1301-9.
15. Guo X, Zheng L, Wang J, et al (2013). Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Med, 14, 324-32.
16. Harrell FE, Jr., Lee KL, Pollock BG (1988). Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst, 80, 1198-202.
17. Henderson BE, Feigelson HS (2000). Hormonal carcinogenesis. Carcinogenesis, 21, 427-33.
18. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
19. Ikehara S, Iso H, Date C, et al (2009). Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep, 32, 295-301.
20. Jiao L, Duan Z, Sangi-Haghpeykar H, et al (2013). Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer, 108, 213-21.
21. Kakizaki M, Inoue K, Kuriyama S, et al (2008a). Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer, 99, 176-8.
22. Kakizaki M, Kuriyama S, Sone T, et al (2008b). Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer, 99, 1502-5.
23. Knutson KL, Spiegel K, Penev P, et al (2007). The metabolic consequences of sleep deprivation. Sleep Med Rev, 11, 163-78.
24. Knutson KL, Turek FW (2006). The U-shaped association between sleep and health: the 2 peaks do not mean the same thing. Sleep, 29, 878-9.
25. Luo J, Sands M, Wactawski-Wende J, et al (2013). Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol, 177, 42-9.
26. Marshall NS, Glozier N, Grunstein RR (2008). Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev, 12, 289-98.
27. McElroy JA, Newcomb PA, Titus-ErnstoffL, et al (2006). Duration of sleep and breast cancer risk in a large populationbased case-control study. J Sleep Res, 15, 241-9.
28. Meisinger C, Heier M, Lowel H, et al (2007). Sleep duration and sleep complaints and risk of myocardial infarction in middle aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep, 30, 1121-7.
29. Odegaard AO, Koh WP, Yuan JM (2013). Combined lifestyle factors and risk of incident colorectal cancer in a Chinese population. Cancer Prev Res (Phila), 6, 360-7.
30. Orsini N, Bellocco R, Greenland S (2006). Generalized least squares for trend estimation of summarized dose-response data. Stata Journal, 6, 40.
31. Pinheiro SP, Schernhammer ES, Tworoger SS, et al (2006). A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res, 66, 5521-5.
32. Reiter RJ, Korkmaz A (2008). Clinical aspects of melatonin. Saudi Med J, 29, 1537-47.
33. Signal TL, Gale J, Gander PH (2005). Sleep measurement in flight crew: comparing actigraphic and subjective estimates to polysomnography. Aviat Space Environ Med, 76, 1058-63.
34. Steptoe A, Peacey V, Wardle J (2006). Sleep duration and health in young adults. Arch Intern Med, 166, 1689-92.
35. Stevens RG, Blask DE, Brainard GC, et al (2007). Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect, 115, 1357-62.
36. Stone KL, Ewing SK, Ancoli-Israel S, et al (2009). Self-reported sleep and nap habits and risk of mortality in a large cohort of older women. J Am Geriatr Soc, 57, 604-11.
37. Stranges S, Cappuccio FP, Kandala NB, et al (2008a). Crosssectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II Study. Am J Epidemiol, 167, 321-9.
38. Stranges S, Dorn JM, Shipley MJ, et al (2008b). Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol, 168, 1353-64.
39. Sturgeon SR, Luisi N, Balasubramanian R, et al (2012). Sleep duration and endometrial cancer risk. Cancer Causes Control, 23, 547-53.
40. Verkasalo PK, Lillberg K, Stevens RG, et al (2005). Sleep duration and breast cancer: a prospective cohort study. Cancer Res, 65, 9595-600.
41. Vogtmann E, Levitan E, Hale L, et al (2013). Association between Sleep and Breast Cancer Incidence among Postmenopausal Women in the Women's Health Initiative. Sleep, 36, 1437.
42. von Ruesten A, Weikert C, Fietze I, et al (2012). Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One, 7, e30972.
43. Weiderpass E, Sandin S, Inoue M, et al (2012). Risk factors for epithelial ovarian cancer in Japan-results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol, 40, 21-30.
44. Wu AH, Stanczyk FZ, Wang R, et al (2013). Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer, 132, 891-6.
45. Wu AH, Wang R, Koh WP, et al (2008). Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis, 29, 1244-8.
46. Yang WS, Deng Q, Fan WY, et al (2013). Light exposure at night, sleep duration, melatonin and breast cancer: a dose-response analysis of observational studies. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation, (in press).
47. Zeitzer JM, Dijk DJ, Kronauer R, et al (2000). Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol, 526, 695-702.
48. Zhang X, Giovannucci EL, Wu K, et al (2013). Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep, 36, 681-8.